Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

5 Versus 10 Units of Insulin in Hyperkalemia Management: Multi-center, Prospective, Double-blind, Non-inferiority, Randomized Control Trial.

NCT06036823 is registered in ClinicalTrials.gov with Oman Medical Speciality Board as lead sponsor.

NCT NCT06036823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06036823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
5 Versus 10 Units of Insulin in Hyperkalemia Management: Multi-center, Prospective, Double-blind, Non-inferiority, Randomized Control Trial.
Lead sponsor
Oman Medical Speciality Board
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2023
Completion date
September 30, 2025
Enrollment
384 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

electrolyte disturbance, electrolyte imbalance, hyperkalemia, potassium imbalance